Clinical Trials Browser

Recruiting × 1-dodecylpyridoxal × 1 year × Clear all

NCT06161025 2026-01-12

A Study of Raludotatug Deruxtecan (R-DXd) in Subjects With Platinum-resistant, High-grade Ovarian, Primary Peritoneal, or Fallopian Tube Cancer

Phase 2/3 Recruiting

Fallopian Tube Neoplasms, Ovarian Neoplasms

NCT05271318 2025-11-03

PROTA

Phase 1/2 Recruiting

Adenoviridae Infections